| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |